Search Results - "Storb, Rainer F"

Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation by Sorror, Mohamed L, Storb, Rainer F, Sandmaier, Brenda M, Maziarz, Richard T, Pulsipher, Michael A, Maris, Michael B, Bhatia, Smita, Ostronoff, Fabiana, Deeg, H Joachim, Syrjala, Karen L, Estey, Elihu, Maloney, David G, Appelbaum, Frederick R, Martin, Paul J, Storer, Barry E

“…Age has long been used as a major factor for assessing suitability for allogeneic hematopoietic cell transplantation (HCT). The HCT-comorbidity index (HCT-CI)…”
Get full text

The role of B cells in the pathogenesis of graft-versus-host disease by Shimabukuro-Vornhagen, Alexander, Hallek, Michael J., Storb, Rainer F., von Bergwelt-Baildon, Michael S.

“…Allogeneic hematopoietic stem cell transplantation is an established treatment modality for malignant and nonmalignant hematologic diseases. Acute and chronic…”
Get full text

Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria by Flowers, Mary E.D., Inamoto, Yoshihiro, Carpenter, Paul A., Lee, Stephanie J., Kiem, Hans-Peter, Petersdorf, Effie W., Pereira, Shalini E., Nash, Richard A., Mielcarek, Marco, Fero, Matthew L., Warren, Edus H., Sanders, Jean E., Storb, Rainer F., Appelbaum, Frederick R., Storer, Barry E., Martin, Paul J.

“…Risk factors for grades 2-4 acute graft-versus-host disease (GVHD) and for chronic GVHD as defined by National Institutes of Health consensus criteria were…”
Get full text

Life Expectancy in Patients Surviving More Than 5 Years After Hematopoietic Cell Transplantation by MARTIN, Paul J, COUNTS, George W, STORER, Barry E, APPELBAUM, Frederick R, LEE, Stephanie J, SANDERS, Jean E, JOACHIM DEEG, H, FLOWERS, Mary E. D, SYRJALA, Karen L, HANSEN, John A, STORB, Rainer F

“…PURPOSE Hematopoietic cell transplantation can cure hematologic malignancies and other diseases, but this treatment can also cause late complications. Previous…”
Get full text

Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality by Sorror, Mohamed L., Martin, Paul J., Storb, Rainer F., Bhatia, Smita, Maziarz, Richard T., Pulsipher, Michael A., Maris, Michael B., Davis, Christopher, Deeg, H. Joachim, Lee, Stephanie J., Maloney, David G., Sandmaier, Brenda M., Appelbaum, Frederick R., Gooley, Theodore A.

“…Whether the hematopoietic cell transplantation comorbidity index (HCT-CI) can provide prognostic information about development of acute graft-versus-host…”
Get full text

Thyroid function following hematopoietic cell transplantation in children: 30 years' experience by Sanders, Jean E., Hoffmeister, Paul A., Woolfrey, Ann E., Carpenter, Paul A., Storer, Barry E., Storb, Rainer F., Appelbaum, Frederick R.

“…Thyroid dysfunction is a known complication after hematopoietic cell transplantation (HCT) in children with reports involving relatively short follow-up and…”
Get full text

Risks and outcomes of invasive fungal infections in recipients of allogeneic hematopoietic stem cell transplants after nonmyeloablative conditioning by Fukuda, Takahiro, Boeckh, Michael, Carter, Rachel A., Sandmaier, Brenda M., Maris, Michael B., Maloney, David G., Martin, Paul J., Storb, Rainer F., Marr, Kieren A.

“…The incidence of invasive mold infections has increased during the 1990s among patients undergoing allogeneic hematopoietic stem cell transplantation (HCT)…”
Get full text

Influence of immunosuppressive treatment on risk of recurrent malignancy after allogeneic hematopoietic cell transplantation by Inamoto, Yoshihiro, Flowers, Mary E.D., Lee, Stephanie J., Carpenter, Paul A., Warren, Edus H., Deeg, H. Joachim, Storb, Rainer F., Appelbaum, Frederick R., Storer, Barry E., Martin, Paul J.

“…This study was conducted to elucidate the influence of immunosuppressive treatment (IST) and GVHD on risk of recurrent malignancy after allogeneic…”
Get full text

Late effects among pediatric patients followed for nearly 4 decades after transplantation for severe aplastic anemia by Sanders, Jean E., Woolfrey, Ann E., Carpenter, Paul A., Storer, Barry E., Hoffmeister, Paul A., Deeg, H. Joachim, Flowers, Mary E.D., Storb, Rainer F.

“…Aplastic anemia (AA), a potentially fatal disease, may be cured with marrow transplantation. Survival in pediatric patients has been excellent early after…”
Get full text

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience by Rezvani, Andrew R., Norasetthada, Lalitha, Gooley, Ted, Sorror, Mohamed, Bouvier, Michelle E., Sahebi, Firoozeh, Agura, Edward, Chauncey, Thomas, Maziarz, Richard T., Maris, Michael, Shizuru, Judith, Bruno, Benedetto, Bredeson, Christopher, Lange, Thoralf, Yeager, Andrew, Sandmaier, Brenda M., Storb, Rainer F., Maloney, David G.

“…Summary Patients with relapsed diffuse large B‐cell lymphoma (DLBCL) who have failed or are ineligible for autologous haematopoietic cell transplantation (HCT)…”
Get full text

Separation of graft-vs.-tumor effects from graft-vs.-host disease in allogeneic hematopoietic cell transplantation by Rezvani, Andrew R, Storb, Rainer F

“…Abstract Allogeneic hematopoietic cell transplantation (HCT) is an increasingly widely used treatment modality in hematological malignancies. Alloreactivity…”
Get full text

Response endpoints and failure-free survival after initial treatment for acute graft-versus-host disease by Inamoto, Yoshihiro, Martin, Paul J, Storer, Barry E, Mielcarek, Marco, Storb, Rainer F, Carpenter, Paul A

“…We evaluated short-term response endpoints for acute graft-versus-host disease treatment trials. We postulated that response endpoints should correlate with…”
Get full text

Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation by Rotta, Marcello, Storer, Barry E., Storb, Rainer F., Martin, Paul J., Heimfeld, Shelly, Peffer, Amanda, Maloney, David G., Deeg, H. Joachim, Sandmaier, Brenda M., Appelbaum, Frederick R., Mielcarek, Marco

“…We retrospectively analyzed outcomes among 567 patients with hematologic malignancies who had hematopoietic cell transplantation from human leukocyte…”
Get full text

Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation by Fukuda, Takahiro, Hackman, Robert C., Guthrie, Katherine A., Sandmaier, Brenda M., Boeckh, Michael, Maris, Michael B., Maloney, David G., Deeg, H. Joachim, Martin, Paul J., Storb, Rainer F., Madtes, David K.

“…Idiopathic pneumonia syndrome (IPS) is a significant noninfectious complication of hematopoietic stem cell transplantation (HSCT). We compared the incidences…”
Get full text

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide by Luznik, Leo, O'Donnell, Paul V, Symons, Heather J, Chen, Allen R, Leffell, M. Susan, Zahurak, Marianna, Gooley, Ted A, Piantadosi, Steve, Kaup, Michele, Ambinder, Richard F, Huff, Carol Ann, Matsui, William, Bolaños-Meade, Javier, Borrello, Ivan, Powell, Jonathan D, Harrington, Elizabeth, Warnock, Sandy, Flowers, Mary, Brodsky, Robert A, Sandmaier, Brenda M, Storb, Rainer F, Jones, Richard J, Fuchs, Ephraim J

“…Abstract We evaluated the safety and efficacy of high-dose, posttransplantation cyclophosphamide (Cy) to prevent graft rejection and graft-versus-host disease…”
Get full text

Pharmacodynamics of mycophenolate mofetil after nonmyeloablative conditioning and unrelated donor hematopoietic cell transplantation by Giaccone, Luisa, McCune, Jeannine S., Maris, Michael B., Gooley, Theodore A., Sandmaier, Brenda M., Slattery, John T., Cole, Scott, Nash, Richard A., Storb, Rainer F., Georges, George E.

“…The immunosuppressive drug mycophenolate mofetil (MMF) is used after nonmyeloablative hematopoietic cell transplantation (HCT); however, limited…”
Get full text

Allogeneic hematopoietic cell transplantation: the state of the art by Gyurkocza, Boglarka, Rezvani, Andrew, Storb, Rainer F

“…Allogeneic hematopoietic cell transplantation (HCT) is a potentially curative procedure for a variety of hematologic malignancies. The field has evolved…”
Get more information

Role of comorbidities in optimizing decision-making for allogeneic hematopoietic cell transplantation by Sorror, Mohamed L, Storb, Rainer F

“…Allogeneic conventional hematopoietic cell transplantation (HCT) following high-dose, myeloablative conditioning regimens has been used since the 1970's as…”
Get full text

Ultrasound-targeted Microbubble Destruction-mediated Gene Delivery Into Canine Livers by Noble, Misty L, Kuhr, Christian S, Graves, Scott S, Loeb, Keith R, Sun, Samuel S, Keilman, George W, Morrison, Kyle P, Paun, Marla, Storb, Rainer F, Miao, Carol H

“…Ultrasound (US) was applied to a targeted canine liver lobe simultaneously with injection of plasmid DNA (pDNA)/microbubble (MB) complexes into a portal vein…”
Get full text

Y-Ibritumomab tiuxetan, fludarabine, and TBI-based nonmyeloablative allogeneic transplantation conditioning for patients with persistent high-risk B-cell lymphoma by Gopal, Ajay K, Guthrie, Katherine A, Rajendran, Joseph, Pagel, John M, Oliveira, George, Maloney, David G, Matesan, Manuela C, Storb, Rainer F, Press, Oliver W

“…Nonmyeloablative allogeneic transplantation (NMAT) infrequently cures active chemoresistant, bulky, or aggressive B-cell lymphoma (B-cell non-Hodgkin lymphoma…”
Get full text